The specificity of neutralizing antibody responses to rotavirus proteins VP4 and VP7 differs depending on whether the infection is symptomatic or asymptomatic/past exposure.
No takes yet. Share an insight, caveat, or question.
Symptom-dependent rotavirus antibody patterns should not yet inform clinical decisions; leaves open mechanisms of protective immunity for prospective studies.
Brüssow et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: